GlassScriptPhysician profile
Dominic Rizzo
NPI 1043283047
$302,635.27
in general payments reported to CMS, 2019-2025
35 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80K · 2020: $49K · 2021: $52K · 2022: $46K · 2023: $30K · 2024: $24K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $60K · Consulting Fee: $8,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,938 · Food and Beverage: $2,475 · Travel and Lodging: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $59,808.18 |
| Consulting Fee | $8,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,937.50 |
| Food and Beverage | $2,475.31 |
| Travel and Lodging | $827.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dne LLC | $140,630.69 | 2019-2023 | Seal |
| Depuy Synthes Sales INC. | $79,623.39 | 2022-2025 | Motoband |
| Crossroads Extremity Systems, LLC | $52,462.20 | 2019-2021 | |
| Integra Lifesciences Corporation | $7,758.30 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bioness INC | $5,125.00 | 2021 | |
| Bioventus LLC | $4,495.51 | 2019-2023 | Stimrouter Implantable Kit |
| Bone Support INC. | $3,352.78 | 2021-2022 | |
| Smith+Nephew, INC. | $2,881.53 | 2019-2025 | Grafix Pl, Stravix, Grafix |
| Ossio INC | $1,500.00 | 2024 | |
| Orthofix Medical, INC. | $988.80 | 2019-2024 | Truelok, Physio-Stim |
| Stryker Corporation | $930.60 | 2019-2024 | Augment Injectable, Easyfuse, Viaflow |
| Kerecis Limited | $415.30 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medshape, INC. | $315.33 | 2024 | Dynanail Helix, Washer, 15 Mm, Dynanail |
| Organogenesis INC. | $311.55 | 2020-2024 | Puraply |
| Checkpoint Surgical, INC | $221.18 | 2020-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $179.55 | 2022-2024 | Restrata Wound Matrix |
| Arteriocyte Medical Systems, INC. | $178.63 | 2019-2022 | |
| Convatec INC. | $158.64 | 2025 | |
| Paragon 28, INC. | $152.77 | 2019-2024 | Monkey Rings |
| Medline Industries LP | $144.36 | 2019 | |
| Kci USA, INC. | $129.17 | 2019-2023 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Misonix INC | $104.20 | 2020-2021 | |
| Osiris Therapeutics INC. | $100.52 | 2019 | |
| Legacy Ortho LLC | $81.30 | 2025 | |
| Medtronic, INC. | $74.28 | 2022 | |
| Boston Scientific Corporation | $55.23 | 2019 | |
| Amgen INC. | $50.48 | 2024-2025 | Krystexxa |
| Axogen | $47.97 | 2021 | |
| Mimedx Group, INC. | $40.10 | 2024 | |
| Treace Medical Concepts, INC. | $33.24 | 2023-2024 | |
| Arthrex, INC. | $24.00 | 2025 | |
| Stimwave Technologies Incorporated | $20.97 | 2022 | |
| Zimmer Biomet Holdings, INC. | $16.80 | 2020 | |
| Heron Therapeutics, INC. | $15.95 | 2022 | |
| Abbvie INC. | $14.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$30,067.55 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dominic Rizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.